Renal Osteodystrophy: α-Heremans Schmid Glycoprotein/Fetuin-A, Matrix GLA Protein Serum Levels, and Bone Histomorphometry
- 31 July 2006
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 48 (1) , 106-113
- https://doi.org/10.1053/j.ajkd.2006.03.083
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Inhibition of Calcium Phosphate Precipitation by Fetuin Is Accompanied by the Formation of a Fetuin-Mineral ComplexJournal of Biological Chemistry, 2003
- α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and RemodelingJournal of Biological Chemistry, 2002
- Matrix Gla Protein Is a Developmental Regulator of Chondrocyte Mineralization And, When Constitutively Expressed, Blocks Endochondral and Intramembranous Ossification in the LimbThe Journal of cell biology, 1999
- Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patientsNephrology Dialysis Transplantation, 1998
- Expression of Bone Matrix Proteins mRNA During Distraction OsteogenesisJournal of Bone and Mineral Research, 1998
- Fetuin/α2-HS Glycoprotein Is a Transforming Growth Factor-β Type II Receptor Mimic and Cytokine AntagonistPublished by Elsevier ,1996
- α2-HS-glycoprotein: Expression in chondrocytes and augmentation of alkaline phosphatase and phospholipase A2 activityBone, 1991
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Origin of plasma α2HS-glycoprotein and its accumulation in boneNature, 1976
- Localisation of plasma α2HS glycoprotein in mineralising human boneNature, 1975